Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : New drug crawled time : 12:03 save search
BioCryst Announces FDA Approval of Supplemental New Drug Application for RAPIVAB® Expanding Patient Population to Include Children Six Months and Older
Published: 2021-02-03 (Crawled : 12:03) - globenewswire.com
BCRX | $4.44 -1.33% -1.35% 4.7M
|
Health Technology
|
| O: 5.41%
H: 0.45%
C: -7.21%
fda approval fda drug approval new drug children application order
Rockwell Medical Announces Submission of Triferic® New Drug Application in South Korea by Partner, Jeil Pharmaceutical Co., Ltd.
Published: 2021-02-01 (Crawled : 12:03) - globenewswire.com
RMTI | $1.46 -1.35% -1.37% 82K
|
Health Technology
|
| O: 5.5%
H: 1.9%
C: -1.26%
drug submission new drug application
Iterum Therapeutics Announces U.S. FDA Filing Acceptance of New Drug Application for Oral Sulopenem
Published: 2021-01-25 (Crawled : 12:03) - globenewswire.com
ITRM | $1.43 -0.69% 60K
|
Health Technology
|
| O: 11.05%
H: 1.42%
C: -14.22%
fda drug sulopenem new drug application
C4 Therapeutics Announces FDA Clearance of Investigational New Drug Application for CFT7455, an Orally Bioavailable MonoDAC for Hematologic Malignancies
Published: 2021-01-19 (Crawled : 12:03) - globenewswire.com
CCCC | $6.74 -2.46% -2.52% 1.7M
|
Health Technology
|
| O: 3.13%
H: 3.94%
C: 0.05%
fda clearance fda drug new drug application clearance
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
GBR | $1.42 31.48% 11.27% 990K
|
Energy Minerals
KUKE | $2.88 2.49% 7.64% 360K
|
MPLN | $0.6502 -11.74% 4.51% 2.2M
|
Finance
CXM 4 | $11.34 -0.44% 4.27% 1.7M
|
Information
PVL 4 | $1.47 -0.68% 4.08% 77K
|
Energy Minerals
RNR 4 | $224.74 0.85% 3.52% 310K
|
Finance
PZG | $0.4431 0.48% 2.91% 150K
|
Non-Energy Minerals
DBRG | $17.3 0.06% 1.97% 1.2M
|
Finance and Insurance
RC | $8.62 1.77% 0.81% 1M
|
Finance
SIX | $23.45 -0.55% 0.68% 650K
|
Consumer Services
Your saved searches
Save your searches and get alerts when important news are released.